Fábio Cardoso Borges (Fábio C Borges)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

Pharmacoepidemiology and drug safety

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Filipa Alves da Costa, Adriana Ramos, Catarina Bernardo, Fábio Cardoso Borges, Ana Costa Miranda, null null
Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal. Scientific reports 13 (1) (2023)
Fábio Cardoso Borges, Adriana Ramos, António Lourenço, Maria Gomes da Silva, Ana Miranda, null null
Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study. PloS one 16 (10) (2021)
Fábio Cardoso Borges, Catarina Ramos, Adriana Ramos, Gonçalo P Mendes, Rodrigo Murteira, Patrícia Soares, Claudia Furtado, Ana C Miranda, Filipa Alves da Costa, null null
Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry. Pharmacoepidemiology and drug safety 30 (3) (2020)
Rodrigo Murteira, Fábio Cardoso Borges, Gonçalo Pinto Mendes, Catarina Ramos, Adriana Ramos, Patrícia Soares, Cláudia Furtado, Ana Miranda, Filipa Alves da Costa, null null
Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study. Pharmacoepidemiology and drug safety 29 (10) (2020)